AIM Vaccine Co., Ltd. engages in biological vaccine technology development, technology transfer, and technical services. The company is headquartered in Beijing, Beijing and currently employs 1,493 full-time employees. The company went IPO on 2022-10-06. The firm's commercialized products mainly include recombinant HBV vaccine, freeze dried human rabies vaccine, inactivated HAV vaccine, mumps vaccine, bivalent inactivated HFRS vaccine and Group A, C, Y and W135 MPSV. The firm's vaccine products under development include 13-Valent Pneumonia Conjugate Vaccine, 24-Valent Pneumonia Conjugate Vaccine, quadrivalent influenza virus vaccine, iterative serum-free rabies vaccine, mRNA shingles/herpes zoster vaccine, Iterative mRNA rabies vaccine, mRNA respiratory syncytial virus vaccine, novel-process highly-effective human diploid rabies vaccine, and others.
06660.HK stock price ended at $3.09 on 금요일, after rising 0.65%
On the latest trading day Feb 13, 2026, the stock price of 06660.HK rose by 0.65%, climbing from $3.11 to $3.09. Throughout the session, the stock experienced a volatility of 2.28%, with prices fluctuating between a daily low of $3.07 and a high of $3.14. Alongside this price increase, trading volume also rose by 1.4M shares, reflecting strong market interest that may signal continued bullish momentum in the near term. In total, 347.2K shares were traded, amounting to a market value of approximately $1.5B.
06660.HK 기술적 시그널
기술적 시그널 요약
구매 신호 3
중립 신호 0
매도 신호 4
Strong Sell
Sell
Neutral
Buy
Strong Buy
06660.HK은 현재 3개의 매수 신호와 4개의 매도 신호를 보이고 있습니다. 이 주식은 12:00 AM 이후로 상승 추세 상태에 있으며, 이 기간 동안 총 가격 변동률은 0.65%입니다. 전반적으로 기술적 지표들은 중기적으로 Sell 전망을 나타내고 있습니다.
06660.HK에 대한 강세/약세 신호
이동평균, RSI, MACD, 거래량 등 핵심 지표를 분석하여 06660.HK 의 강세/약세 시그널을 생성합니다. 이 인사이트를 활용해 더 현명한 투자 결정을 내리세요.